These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
292 related items for PubMed ID: 10979944
1. Solitary plasmacytoma of bone and asymptomatic multiple myeloma. Dimopoulos MA, Moulopoulos LA, Maniatis A, Alexanian R. Blood; 2000 Sep 15; 96(6):2037-44. PubMed ID: 10979944 [Abstract] [Full Text] [Related]
2. Solitary plasmacytoma of bone and asymptomatic multiple myeloma. Dimopoulos MA, Moulopoulos A, Delasalle K, Alexanian R. Hematol Oncol Clin North Am; 1992 Apr 15; 6(2):359-69. PubMed ID: 1582978 [Abstract] [Full Text] [Related]
3. Radiation Therapy for Solitary Plasmacytoma and Multiple Myeloma: Guidelines From the International Lymphoma Radiation Oncology Group. Tsang RW, Campbell BA, Goda JS, Kelsey CR, Kirova YM, Parikh RR, Ng AK, Ricardi U, Suh CO, Mauch PM, Specht L, Yahalom J. Int J Radiat Oncol Biol Phys; 2018 Jul 15; 101(4):794-808. PubMed ID: 29976492 [Abstract] [Full Text] [Related]
4. Plasmacytoma of the mastoid bone: solitary and systemic. Engelsma RJ, De Bree R, Janssen JJ, Scheeren RA. J Laryngol Otol; 2000 May 15; 114(5):378-80. PubMed ID: 10912271 [Abstract] [Full Text] [Related]
5. Metachronous solitary plasmacytoma. Khosa R, Seth S, Nangia S. BMJ Case Rep; 2017 Oct 19; 2017():. PubMed ID: 29054949 [Abstract] [Full Text] [Related]
6. Radiotherapy for the treatment of solitary plasmacytoma: 7-year outcomes by a mono-institutional experience. Alghisi A, Borghetti P, Maddalo M, Roccaro AM, Tucci A, Mazzola R, Magrini SM, Lo Casto A, Bonù ML, Tomasini D, Pasinetti N, Peretto G, Bertagna F, Tomasi C, Buglione M, Triggiani L. J Cancer Res Clin Oncol; 2021 Jun 19; 147(6):1773-1779. PubMed ID: 33201300 [Abstract] [Full Text] [Related]
7. Up-date on solitary plasmacytoma and its main differences with multiple myeloma. Di Micco P, Di Micco B. Exp Oncol; 2005 Mar 19; 27(1):7-12. PubMed ID: 15812350 [Abstract] [Full Text] [Related]
11. Persistence of myeloma protein for more than one year after radiotherapy is an adverse prognostic factor in solitary plasmacytoma of bone. Wilder RB, Ha CS, Cox JD, Weber D, Delasalle K, Alexanian R. Cancer; 2002 Mar 01; 94(5):1532-7. PubMed ID: 11920511 [Abstract] [Full Text] [Related]
12. [Solitary myeloma of the bone]. Grigorova TM. Klin Med (Mosk); 1973 Dec 01; 51(12):117-9. PubMed ID: 4779013 [No Abstract] [Full Text] [Related]
15. [Solitary plasmacytoma (osseous and extra-osseous)]. Simon F. Rev Prat; 1979 Jan 11; 29(3):353-8. PubMed ID: 419357 [No Abstract] [Full Text] [Related]
16. Plasmacytoma. Treatment results and conversion to myeloma. Holland J, Trenkner DA, Wasserman TH, Fineberg B. Cancer; 1992 Mar 15; 69(6):1513-7. PubMed ID: 1540888 [Abstract] [Full Text] [Related]
17. [Extramedullary plasmacytoma]. Sucker C, Stockschläder M. Dtsch Med Wochenschr; 2002 Jan 25; 127(4):153-5. PubMed ID: 11807659 [No Abstract] [Full Text] [Related]
19. [Rare intracranial plasmacytoma manifestations. Case reports and review of the literature in diffuse plasmocytoma, in primary solitary extramedullary plasmacytoma in in primary solitary osseous plasmacytoma]. Kujat C, Reiche W, Koch B, Moringlane JR. Radiologe; 1996 Nov 25; 36(11):914-20. PubMed ID: 9036433 [Abstract] [Full Text] [Related]